HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claire Ambery Selected Research

Pneumonia (Pneumonitis)

6/2020CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claire Ambery Research Topics

Disease

8Chronic Obstructive Pulmonary Disease (COPD)
08/2022 - 10/2013
1Pneumonia (Pneumonitis)
06/2020
1Inflammation (Inflammations)
06/2020
1Respiratory Tract Diseases (Respiratory Tract Disease)
11/2019
1Asthma (Bronchial Asthma)
12/2014
1Dysgeusia (Parageusia)
10/2013
1Tremor (Tremors)
10/2013
1Allergic Rhinitis
01/2012
1Seasonal Allergic Rhinitis (Hay Fever)
01/2012

Drug/Important Bio-Agent (IBA)

4danirixinIBA
06/2020 - 08/2017
3batefenterolIBA
11/2018 - 10/2013
2Interleukin-8B ReceptorsIBA
06/2020 - 11/2019
1SaltsIBA
08/2017
13- (3- tert- butylsulfanyl- 1- (4- (6- ethoxypyridin- 3- yl)benzyl)- 5- (5- methylpyridin- 2- ylmethoxy)- 1H- indol- 2- yl)- 2,2- dimethylpropionic acidIBA
12/2014
1Salmeterol Xinafoate (Serevent)FDA Link
10/2013
1Ipratropium (Ipratropium Bromide)FDA LinkGeneric
10/2013
1Tiotropium Bromide (Spiriva)FDA Link
10/2013
1Albuterol (Salbutamol)FDA LinkGeneric
10/2013
1GSK 1004723IBA
01/2012
1AllergensIBA
01/2012
1Histamine (Histamine Dihydrochloride)FDA Link
01/2012
1SuspensionsIBA
01/2012

Therapy/Procedure

1Therapeutics
08/2022